Insulin Pen Needle is used to inject insulin into the body of a diabetic patient. An insulin pen consists of a hollow disposable needle, an insulin cartridge, and a dial to measure the dosage required. Insulin needle is considered to be the easiest and safest way to inject insulin. Technological advancements in terms of needle length have increased the adoption of insulin pen needles in developed countries and hence it is expected to augment the market growth over the forecast period of 2017-2025.Pen needles have a fine pointed tip which makes it easier to penetrate the human muscle. This altered length makes it easier to deliver drug or insulin to a patient. A pen needle, whose length is short, can be used by any patient including overweight patients too.
In 2013, Becton, Dickinson and Company along with Easy Flow Technology made BD Ultra Fine- a 4mm (nano-length) pen needle. In 2014, NovoNordisk produced NovoFine Plus- a pen needle which is thinnest, and quite shortest in length
Insulin pen needles act as an alternative drug delivery process. The rising population of diabetes patients is estimated to propel the global insulin pen needles market and boost the product development initiatives. Ease handling, portability, and availability of insulin pen needles are some of the major advantages that are expected to make a positive impact on the market. Pen needles of nano length can be easily used by obese patients. Furthermore, the growing level of awareness among the diabetic population regarding self-administration of insulin pens attributes to the growth of this segment.
The major application of insulin pen needles includes type I diabetes, and type II diabetes. The insulin pen needle market is further segmented byproduct types which include standard insulin pen needle, and safety insulin pen needle. Based on the needle length, it includes from 4mm to 12mm. These lengths are also known as nano, medium, and long length. Based on therapy, the insulin pen needle market is bifurcated as insulin/diabetes, growth hormone, and glucagon-like-peptide-1. Moving forward, based on the end-users, the insulin pen needle market is analyzed as hospitals, home healthcare, clinics, OTC, and others. Based on geographical segmentation, the global insulin pen needles market is analyzed in North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
Moreover, among the different types of insulin pen needles, the standard pen needle segment is witnessing a huge market growth owing to its accessibility. Among the needle lengths, 4mm is estimated to have an attractive growth due to its nano length. However, 8mm holds the largest share in the market due to the convenience it offers to the diabetic patients. Furthermore, amongst the therapies, insulin holds the largest share in the market due to the growing awareness of self-administration in sustaining threats of diabetes among the diabetic patients.
In addition to this, the high occurrence of diabetes in Europe, and North-America makes both the regions hold the largest market share. Moreover, the Asia-Pacific region is estimated to display the highest growth rate followed by Middle-East and Latin-America, owing to the rising awareness among the diabetic population.
However, increasing preference for non-invasive medical devices may pose a threat to the global insulin pen needlesmarket in the near future.
Some of the key players in the global insulin pen needles market include UltiMed Inc., Becton, Dickinson, and Company, Novo Nordisk A/S, Ypsomed Holding AG, Owen Mumford Limited, B Braun Melsungen AG, Terumo Corporation, MedExel Co., Allison Medical Inc.
Global Insulin Pen Needle Market: By Types
Global Insulin Pen Needle Market: By Length
Global Insulin Pen Needle Market: By Therapy
Global Insulin Pen Needle Market: By Application
Global Insulin Pen Needle Market: By End-Users
Global Insulin Pen Needle Market: By Geography